CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
Chen S, Dai Y, Pei XY, Myers J, Wang L, Kramer LB, Garnett M, Schwartz DM, Su F, Simmons GL, Richey JD, Larsen DG, Dent P, Orlowski RZ, Grant S.
Chen S, et al. Among authors: larsen dg.
Cancer Res. 2012 Aug 15;72(16):4225-37. doi: 10.1158/0008-5472.CAN-12-1118. Epub 2012 Jun 12.
Cancer Res. 2012.
PMID: 22693249
Free PMC article.